|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Glucocorticoids are essential for lung maturation and pharmacologic doses of glucocorticoids increase
surfactant in adult rats. Therefore, we asked if glucocorticoid deficiency in corticotropin-releasing hormone-deficient mice (CRH
/
) with very low plasma corticosterone levels would alter surfactant
pool sizes and precursor incorporation into saturated phosphatidylcholine (Sat PC). Alveolar and
lung tissue Sat PC pool sizes were not different for CRH
/
mice and wild-type mice. The incorporation of [3H]choline into Sat PC also was similar for the two strains of mice. Glucocorticoids are not a
major regulator of surfactant homeostasis in the adult mouse.
| |
INTRODUCTION |
|---|
|
|
|---|
Glucocorticoids are critical regulators of the surfactant system
in late fetal life (1), and antenatal glucocorticoids given to women
at risk of preterm delivery decrease respiratory distress syndrome (2). Exposure of human fetal lung explants to glucocorticoids accelerates the appearance of surfactant components (3). The essential requirement of glucocorticoids for late gestational lung maturation recently was demonstrated by the observations that fetal mice deficient for corticotropin-releasing
hormone (CRH) or deficient for glucocorticoid receptors will
die of respiratory failure after birth (4, 5). The lungs have an
arrest in terminal bronchiolar and alveolar development from
Day 15.5 postconception and inadequate surfactant function.
In the adult rat, high-dose glucocorticoids selectively increase
lamellar body and alveolar saturated phosphatidylcholine (Sat
PC) and surfactant protein A (SP-A) pools without increases
in phospholipids in other lung cell fractions or in other organs (6, 7). Although very little is known about how the normal
lung regulates surfactant pools, hormones do influence surfactant metabolism.
-Agonists cause surfactant secretion (8), and
granulocyte-macrophage colony stimulating factor (GM-CSF)
deficiency results in catabolic abnormalities (9). We hypothesized that glucocorticoids contribute to normal surfactant homeostasis. We evaluated the lung tissue and alveolar pools of
Sat PC as well as radiolabeled choline incorporation in adult
mice with very low plasma corticosterone levels secondary to
CRH deficiency.
| |
METHODS |
|---|
|
|
|---|
Mice
Breeding pairs of C57B1/6J CRH
/
and normal CRH+/+ mice
were the kind gift of Dr. Joseph A. Majzoub, Harvard Medical
School. The CRH
/
mice were maintained on water containing 30 µg/ml corticosterone for the period from breeding to about 2 wk after
delivery of the pups because CRH
/
mice will not breed unless
given supplemental glucocorticoids (4). All mice were then allowed to
grow without glucocorticoid supplementation until 6 to 8 wk of age.
Because Muglia and coworkers (4) found that the baseline corticosterone levels and stress levels were higher in female CRH
/
mice than male CRH
/
mice, we recorded the sex of each animal studied.
Surfactant Measurements
The mice were given a weight-adjusted intraperitoneal injection of 50 µCi/kg [3H]choline chloride (American Radiolabeled Chemical, St. Louis, MO), and the animals were deeply anesthetized 8 h later with intraperitoneal pentobarbital (9). The chest of each animal was opened and blood was drawn for the subsequent assay of corticosterone. The lungs then were processed as previously described (9). In brief, a 20-gauge catheter was tied into the trachea and an extensive alveolar wash was recovered for each animal. The lungs were then homogenized in saline.
Analytic Techniques
Saturated phosphatidylcholine (Sat PC) was recovered by chromatography using neutral alumina columns from chloroform:methanol (2:1) extracts of alveolar washes and lung homogenates (10). The amount of Sat PC was measured by phosphorus assay (11). Plasma corticosterone was measured using a kit from ICN (Costa Mesa, CA).
Data Analysis
All values are given as means ± SE. Differences between groups were evaluated using unpaired two-tailed t tests, with p < 0.05 considered as significant.
| |
RESULTS |
|---|
|
|
|---|
The six male and five female CRH
/
mice weighed 25.6 ± 0.7 and 22.6 ± 1.1 g, respectively. The wild-type mice weighed
23.7 ± 1.3 g (6 male) and 22.5 ± 1.7 g (7 female). Plasma corticosterone values for wild-type male and female mice were
352 ± 5 and 334 ± 19 µg/ml, respectively. Corticosterone values for the CRH
/
mice were very low and could not be reliably measured because they were at the limits of the assay.
Alveolar, lung tissue, and total lung (alveolar plus lung tissue) pool sizes of Sat PC were not different by sex for CRH
/
or wild-type mice. The pool sizes also were not different between CRH
/
mice and wild-type mice (Figure 1A). The total amount of [3H]choline recovered in Sat PC was not different for CRH
/
mice or wild-type mice, and there were no
differences based on sex (Figure 1B).
|
The amount of [3H]choline-labeled Sat PC recovered by alveolar wash was lower for wild-type mice than for CRH
/
mice. The percent secreted at 8 h estimated as the amount of
[3H]Sat PC in the alveolar washes divided by the [3H]Sat PC in
the lungs of each animal was lower for wild-type than for
CRH
/
mice. This difference resulted from a lower percent secretion in female wild-type mice (10.2 ± 2%) than for female CRH
/
mice (20.1 ± 0.7%). Percent secretion for
male wild-type mice was 15.6 ± 2.8% and for male CRH
/
mice was 17.9 ± 1.8%, values that were not significantly different.
| |
DISCUSSION |
|---|
|
|
|---|
These experiments were based on the hypothesis that glucocorticoids would participate in surfactant homeostasis because
they are essential for maturation of the developing lung (4, 5) and pharmacologic doses of glucocorticoids cause large increases in surfactant lipid and protein pools in adult rats (6, 7). The metabolism and function of the surfactant system is complex, and these experiments did not evaluate numbers of type
II cells and processes such as recycling and alveolar form conversions (9). However, Sat PC pool sizes were normal in
CRH
/
mice, and incorporation of a precursor into Sat PC
was the same for CRH
/
mice and wild-type mice. The percent radiolabeled Sat PC recovered by alveolar wash also was
similar for male CRH
/
and wild-type mice. The only difference identified was a higher percent secretion for female
CRH
/
mice than for female wild-type mice. In previous experiments, normal values for secretion in female mice are similar to the values found for the female CRH
/
mice (9). It is
possible that there are subtle adaptive mechanisms (changes
in type II cell numbers, for example) that reflect abnormalities in surfactant metabolism. However, our overall conclusion is
that surfactant homeostasis is similar for CRH
/
mice and
wild-type mice.
The CRH
/
mice had very low plasma corticosterone
levels and the concentrations measured in the wild-type mice
were similar to stress responses in mice reported previously
(4). These high concentrations were probably the result of the
stress related to terminal anesthesia. Although the CRH
/
mice had received corticosterone via the mother or in the water for the first 2 wk of life, they had not received supplemental glucocorticoid for 4 to 6 wk before study. The 8-h interval
from precursor administration to study was selected based on
previous measurements of Sat PC labeling at multiple times
after precursor administration (12). Maximal incorporation
using labeled choline occurs within several hours after intraperitoneal injection, and degradation is not apparent by 8 h.
Secretion also is close to maximal by 8 h (9), making this single
time point for assessment a reasonable compromise.
Mechanisms regulating surfactant homeostasis are unknown.
Short-term increases in alveolar surfactant occur after
-agonist administration or hyperventilation (8, 13). GM-CSF cytokine or receptor deficiencies result in pulmonary alveolar
proteinosis and slow catabolism of surfactant in mice and humans (14). The GM-CSF-deficient mice appear normal despite
abnormal surfactant homeostasis. Other cytokines such as tumor necrosis factor alpha can acutely suppress surfactant protein B messenger RNA (SP-B mRNA) levels (15). Our results
indicate that glucocorticoids are not important regulators of
surfactant homeostasis in otherwise healthy adult mice.
| |
Footnotes |
|---|
Supported by Grant HD-11932 from the National Institute of Child Health and Development.
Correspondence and requests for reprints should be addressed to Alan H. Jobe, M.D., Ph.D., Children's Hospital Medical Center, Division of Pulmonary Biology, 3333 Burnet Ave., Cincinnati, OH 45229-3039.
(Received in original form January 14, 1998 and in revised form April 7, 1998).
| |
References |
|---|
|
|
|---|
1.
Ballard, P. L.,
Y. Ning,
D. Polk,
M. Ikegami, and
A. H. Jobe.
1997.
Glucocorticoid regulation of surfactant components in immature lambs.
Am. J. Physiol.
273:
L1048-L1057
2.
Crowley, P..
1995.
Antenatal corticosteroid therapy: a meta-analysis of
the randomized trials
1972-1994.
Am. J. Obstet. Gynecol.
173:
322-335
[Medline].
3.
Liley, H. G.,
R. T. White,
B. J. Benson, and
P. L. Ballard.
1988.
Glucocorticoids both stimulate and inhibit production of pulmonary surfactant protein A in fetal human lung.
Proc. Natl. Acad. Sci. U.S.A.
85:
9096-9100
4. Muglia, L., L. Jacobson, P. Dikkes, and J. A. Majzoub. 1995. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 373: 427-432 [Medline].
5. Cole, T. J., J. A. Blendy, A. P. Monaghan, K. Krieglstein, W. Schmid, A. Aguzzi, G. Fantuzzi, E. Hummler, K. Unsicker, and G. Schutz. 1995. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Gene Develop. 9: 1608-1621 .
6.
Young, S. L., and
R. Silbajoris.
1986.
Dexamethasone increases adult rat
lung surfactant lipids.
J. Appl. Physiol.
60:
1665-1672
7.
Young, S. L.,
Y. S. Ho, and
R. A. Silbajoris.
1991.
Surfactant apoprotein
in adult rat lung compartments is increased by dexamethasone.
Am. J. Physiol.
260:
L161-L167
8.
Isohama, Y.,
Y. Kumanda,
K. Tanaka,
H. Kai,
K. Takahama, and
T. Miyata.
1996.
Dexamethasone increases
2-adrenoceptor-regulated
phosphatidylcholine secretion in rat alveolar type II cells.
Jpn. J. Pharmacol.
73:
163-169
.
9.
Ikegami, M.,
T. Ueda,
W. Hull,
J. A. Whitsett,
R. C. Mulligan,
G. Dranoff, and
A. H. Jobe.
1996.
Surfactant metabolism in transgenic mice
after granulocyte macrophage-colony stimulating factor ablation.
Am.
J. Physiol.
270:
L650-L658
10. Mason, R. J., J. Nellenbogen, and J. A. Clements. 1976. Isolation of disaturated phosphatidylcholine with osmium tetroxide. J. Lipid Res. 17: 281-284 [Abstract].
11.
Bartlett, G. R..
1959.
Phosphorous assay in column chromatography.
J.
Biol. Chem.
234:
466-468
12.
Gross, N. J.,
E. Barnes, and
K. R. Narine.
1988.
Recycling of surfactant
in black and beige mice: pool sizes and kinetics.
J. Appl. Physiol.
64:
2017-2025
13.
Nicholas, T. E.,
J. H. T. Power, and
H. A. Barr.
1982.
Surfactant homeostasis in the rat during swimming exercise.
J. Appl. Physiol.
53:
1521-1528
14.
Dirksen, U.,
R. Nishinakamura,
P. Groneck,
U. Hattenhorst,
L. Nogee,
R. Murray, and
S. Burdach.
1997.
Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL/IL-5 receptor common
chain expression.
J. Clin. Invest.
100:
2211-2217
[Medline].
15.
Pryhuber, G. S.,
C. Bachurski,
R. Hirsch,
A. Bacon, and
J. A. Whitsett.
1996.
Tumor necrosis factor-alpha decreases surfactant protein B
mRNA in murine lung.
Am. J. Physiol.
270:
L714-L721
This article has been cited by other articles:
![]() |
G. A. Braems, L.-J. Yao, K. Inchley, A. Brickenden, V. K. M. Han, A. Grolla, J. R. G. Challis, and F. Possmayer Ovine surfactant protein cDNAs: use in studies on fetal lung growth and maturation after prolonged hypoxemia Am J Physiol Lung Cell Mol Physiol, April 1, 2000; 278(4): L754 - L764. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |